UQ receives $5 million from Medical Research Future Fund to improve treatment for post-stroke aphasia

The Queensland Aphasia Research Centre at The University of Queensland has been awarded almost $5 million from the Medical Research Future Fund to improve treatment for the growing number of Australians living with post-stroke aphasia.

The disorder damages the area of the brain that controls language expression and comprehension, often leaving patients unable to communicate effectively.

A team of researchers, healthcare partners, and industry leaders led by UQ's Professor David Copland will create a digital platform for the delivery of evidence-based treatments, tailored for both metropolitan and regional health services.

The platform will provide information and resources to support healthcare teams to deliver coordinated, quality care and monitor outcomes. The platform will also empower people living with aphasia and their carers to self-manage elements of their care.

The work will build on long-standing partnerships with consumers and the design of the platform will address unmet healthcare needs identified in 2 year in depth exploration of people with aphasia.

This study is funded under the Medical Research Future Funds (MRFF) Rapid Applied Research Translation initiative.

QARC was established in partnership with Metro North Health as part of the Surgical, Treatment and Rehabilitation Services Education and Research Alliance, thanks to a $1 million gift from the Bowness Family Foundation and $500,000 from an anonymous donor. 


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH grant supports advancement in cognitive screening after devastating type of stroke